While steroids are associated with the development of cardiovascular disease, anti-rheumatic drugs like methotrexate, tumor necrosis factor (TNF) inhibitors, and IL-6 inhibitors have been reported to mitigate this risk (Crowson et al., 2013; Giachi et al., 2022). This evidence concerns the gene TNF and cardiovascular disorder.